Results 111 to 120 of about 19,810 (255)

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE [PDF]

, 2023
Wendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, Roland de Wind, Nicolas Sirtaine, Pieter Demetter, Marie Vercruyssen, Erwin Woff, Ioannis Karfis, Ghanem E. Ghanem, Patrick Flamen, Zéna Wimana   +11 more
openalex   +1 more source

Aptamer‐Functionalized Nanocarriers for Bone and Joint Diseases: Engineering Design Rules and Translational Roadmap

Small Science, Volume 6, Issue 5, May 2026.
Aptamer‐functionalized nanocarriers represent a versatile platform for targeted therapy in bone and joint diseases. This review presents five complementary design strategies: free aptamers for soluble targets, bispecific multivalent constructs for enhanced avidity, nanoparticle‐conjugated aptamers for selective tissue accumulation, aptamer‐based ...
Hamdi Al‐Azzani, Djandan Tadum Arthur Vithran, Syeda Sundas Batool, Malek Mohammed Ali Alshabi, Wenhu Zhou, Xiaoqiang Mao   +5 more
wiley   +1 more source

A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice [PDF]

, 2017
Folate receptor (FR)-targeted radionuclide therapy using folate radioconjugates is of interest due to the expression of the FR in a variety of tumor types. The high renal accumulation of radiofolates presents, however, a risk of radionephropathy.
Antoine, Daniel, Haller, Stephanie, Kipar, Anja, Müller, Cristina, Pellegrini, Giovanni, Schibli, Roger, Siwowska, Klaudia   +6 more
core   +3 more sources

Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions

Med Research, EarlyView.
Zhiwu Dong, Sixiang Yan, Xiaodong Liu, Peng Gu   +3 more
wiley   +1 more source

Phosphohistone H3 and Ki‐67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective cohort study

Journal of Neuroendocrinology, Volume 38, Issue 5, May 2026.
Abstract Ki‐67 index and mitotic count form the basis of grading of small intestinal neuroendocrine tumours (siNET). We hypothesized that the mitosis‐specific marker phosphohistone H3 (PHH3) might better correlate with cancer‐specific survival (CSS) and with response to treatment. We evaluated the association between Ki‐67 index, PHH3‐estimated mitotic
Dimitrios Papantoniou, Malin Grönberg, Eva Tiensuu Janson   +2 more
wiley   +1 more source

De schoonheid van het verval [PDF]

, 2007
In de tijd dat hoogleraren zich nog een eigen chauffeur konden veroorloven, lang geleden dus, was er een hoogleraar die regelmatig lezingen hield. Op een avond was hij weer op weg naar een lezing en plotseling stelde zijn chauffeur in de auto een ...
Jong, M. (Marion) de
core  

Meeting Notes of the Taiwan Neuroendocrine Tumor Society & Taiwan Society of Nuclear Medicine Joint Conference - Peptide Receptor Radionuclide Therapy Targeting for Gastroenteropancreatic Neuroendocrine Tumors: Basic Principles and State-of-the-art Clinical Practice

Journal of Cancer Research and Practice
Objective: The current study aimed to investigate the basic principles and clinical applications, including the selection of proper candidates, follow-up strategies, and radiation protection issues relating to peptide receptor radionuclide therapy (PRRT).
Mei-Fang Cheng, Chih-Chieh Yen, Jeng-Shiun Du, Yu-Li Chiu, Ming-Huang Chen, Hui-Jen Tsai, I-Chen Wu, Hueng-Yuan Shen, Ruoh-Fang Yen, Li-Tzong Chen, On Behalf of Taiwan Neuroendocrine Tumor Society and Taiwan Society of Nuclear Medicine   +10 more
doaj   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

World Journal of Surgery, EarlyView.
Matilda Anneback, Priya H. Dedhia, Aimee Di Marco, Els Nieveen van Dijkum, Julie A. Miller, Janice L. Pasieka   +5 more
wiley   +1 more source

Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity [PDF]

, 2013
Sobhan Vinjamuri, Timothy Gilbert, Melissa Banks, Gail McKane, P. Maltby, G.J. Poston, H WEISSMAN, Daniel H. Palmer, Jiten Vora, D. Mark Pritchard, Daniel J. Cuthbertson   +10 more
openalex   +1 more source

Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy

, 2022
Abhay Singh, Nuria Mencia-Trinchant, Elizabeth A. Griffiths, Alaa Altahan, Mahesh Swaminathan, Medhavi Gupta, Matthew Gravina, Rutaba Tajammal, Mark G. Faber, LunBiao Yan, Eti Sinha, Duane C. Hassane, David Neil Hayes, Monica L. Guzman, Renuka Iyer, Eunice S. Wang, Swapna Thota   +16 more
openalex   +2 more sources